These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 28351589)

  • 21. Design, synthesis, anti-tumor activity, and molecular modeling of quinazoline and pyrido[2,3-d]pyrimidine derivatives targeting epidermal growth factor receptor.
    Hou J; Wan S; Wang G; Zhang T; Li Z; Tian Y; Yu Y; Wu X; Zhang J
    Eur J Med Chem; 2016 Aug; 118():276-89. PubMed ID: 27132165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids.
    Sharma A; Luxami V; Paul K
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3288-94. PubMed ID: 23611732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and biological evaluation of novel 6-chloro-quinazolin derivatives as potential antitumor agents.
    Luo H; Yang S; Cai Y; Peng Z; Liu T
    Eur J Med Chem; 2014 Sep; 84():746-52. PubMed ID: 25064351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2,4-Disubstituted Quinazoline Derivatives Act as Inducers of Tubulin Polymerization: Synthesis and Cytotoxicity.
    Moghadam ES; Tehrani MH; Csuk R; Fischer L; Faramarzi MA; Rashidi A; Javadi I; Amini M
    Anticancer Agents Med Chem; 2019; 19(8):1048-1057. PubMed ID: 30868963
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors.
    Qin X; Lv Y; Liu P; Li Z; Hu L; Zeng C; Yang L
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1571-1575. PubMed ID: 26879314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives.
    Khodair AI; Alsafi MA; Nafie MS
    Carbohydr Res; 2019 Dec; 486():107832. PubMed ID: 31622868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis, Characterization of 4-Anilino-6,7-Dimethoxy Quinazoline Derivatives as Potential Anti-Angiogenic Agents.
    Devegowda PS; Balaji KS; Prasanna DS; Swaroop TR; Kameshwar VH; Jayarama S; Siddalingaiah L; Rangappa KS
    Anticancer Agents Med Chem; 2018 Feb; 17(14):1931-1941. PubMed ID: 28403784
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quinazoline sulfonamide derivatives targeting MicroRNA-34a/MDM4/p53 apoptotic axis with radiosensitizing activity.
    Soliman AM; Kodous AS; Al-Sherif DA; Ghorab MM
    Future Med Chem; 2024; 16(10):929-948. PubMed ID: 38661115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and antitumor activity of novel quinazoline derivatives containing thiosemicarbazide moiety.
    He J; Wang X; Zhao X; Liang Y; He H; Fu L
    Eur J Med Chem; 2012 Aug; 54():925-30. PubMed ID: 22749192
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimization of gefitinib analogues with potent anticancer activity.
    Yin KH; Hsieh YH; Sulake RS; Wang SP; Chao JI; Chen C
    Bioorg Med Chem Lett; 2014 Nov; 24(22):5247-50. PubMed ID: 25305687
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design, Synthesis, and Antitumor Activity of Novel Quinazoline Derivatives.
    Wang L; Li P; Li B; Wang Y; Li J; Song L
    Molecules; 2017 Sep; 22(10):. PubMed ID: 28956845
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiproliferative evaluation of 13-aryl-13H-benzo[g]benzothiazolo [2,3-b]quinazoline-5,14-diones.
    Wu L; Zhang C; Li W
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1462-5. PubMed ID: 24582982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design and synthesis of novel quinazoline nitrogen mustard derivatives as potential therapeutic agents for cancer.
    Li S; Wang X; He Y; Zhao M; Chen Y; Xu J; Feng M; Chang J; Ning H; Qi C
    Eur J Med Chem; 2013 Sep; 67():293-301. PubMed ID: 23871909
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel N-(3-ethynyl Phenyl)-6,7-bis(2-methoxyethoxy)Quinazoline-4-amine Derivatives: Synthesis, Characterization, Anti-cancer Activity,
    Dash A; Vaddamanu G; Karreddula R; Manubolu SSB; Kumari GP; Mulakayala N
    Anticancer Agents Med Chem; 2024; 24(7):514-532. PubMed ID: 38288814
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sulphonamido-quinoxalines: search for anticancer agent.
    Ingle R; Marathe R; Magar D; Patel HM; Surana SJ
    Eur J Med Chem; 2013 Jul; 65():168-86. PubMed ID: 23708011
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synthesis and anticancer activity of some novel trifluoromethylquinolines carrying a biologically active benzenesulfonamide moiety.
    Al-Dosari MS; Ghorab MM; Alsaid MS; Nissan YM; Ahmed AB
    Eur J Med Chem; 2013 Nov; 69():373-83. PubMed ID: 24077528
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and Cytotoxic Activity of Quinazoline-benzofuran Conjugates.
    Liu Y; Zou N; Li M; Wan C; Mao Z
    Curr Org Synth; 2024; 21(7):928-940. PubMed ID: 37357511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel substituted hydrazono indolo[2,1-b]quinazoline-6,12-dione analogues as cytostatic agents: Synthesis, crystal structure, biological evaluation and molecular docking studies.
    Guda R; Narsimha S; Babu R; Muthadi S; Lingabathula H; Palabindela R; Yellu NR; Kumar G; Kasula M
    Bioorg Med Chem Lett; 2016 Nov; 26(22):5517-5523. PubMed ID: 27769618
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design and Synthesis of 4-substituted Quinazolines as Potent EGFR Inhibitors with Anti-breast Cancer Activity.
    Ahmed MF; Magdy N
    Anticancer Agents Med Chem; 2017; 17(6):832-838. PubMed ID: 27671305
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, anti-cancer evaluation of benzenesulfonamide derivatives as potent tubulin-targeting agents.
    Yang J; Yang S; Zhou S; Lu D; Ji L; Li Z; Yu S; Meng X
    Eur J Med Chem; 2016 Oct; 122():488-496. PubMed ID: 27423028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.